309 related articles for article (PubMed ID: 9637713)
21. The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.
Sokolovic D; Nikolic J; Kocic G; Jevtovic-Stoimenov T; Veljkovic A; Stojanovic M; Stanojkovic Z; Sokolovic DM; Jelic M
Drug Chem Toxicol; 2013 Apr; 36(2):141-8. PubMed ID: 22385135
[TBL] [Abstract][Full Text] [Related]
22. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.
Ljubuncic P; Fuhrman B; Oiknine J; Aviram M; Bomzon A
Gut; 1996 Sep; 39(3):475-8. PubMed ID: 8949657
[TBL] [Abstract][Full Text] [Related]
23. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.
Qiao L; Studer E; Leach K; McKinstry R; Gupta S; Decker R; Kukreja R; Valerie K; Nagarkatti P; El Deiry W; Molkentin J; Schmidt-Ullrich R; Fisher PB; Grant S; Hylemon PB; Dent P
Mol Biol Cell; 2001 Sep; 12(9):2629-45. PubMed ID: 11553704
[TBL] [Abstract][Full Text] [Related]
24. The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes.
Utanohara S; Tsuji M; Momma S; Morio Y; Oguchi K
Toxicology; 2005 Oct; 214(1-2):77-86. PubMed ID: 16023280
[TBL] [Abstract][Full Text] [Related]
25. [Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3].
Ji WJ; Qu Q; Jin Y; Zhao L; He XD
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2997-3001. PubMed ID: 20137712
[TBL] [Abstract][Full Text] [Related]
26. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
28. Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity.
Powell AA; Akare S; Qi W; Herzer P; Jean-Louis S; Feldman RA; Martinez JD
BMC Cancer; 2006 Sep; 6():219. PubMed ID: 16948850
[TBL] [Abstract][Full Text] [Related]
29. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
[TBL] [Abstract][Full Text] [Related]
30. Role of mitochondria in the differential action of sodium deoxycholate and ursodeoxycholic acid on rat duodenum.
Pérez A; Rivoira MA; Rodríguez V; Marchionatti A; Tolosa de Talamoni N
Can J Physiol Pharmacol; 2021 Mar; 99(3):270-277. PubMed ID: 32687730
[TBL] [Abstract][Full Text] [Related]
31. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
[TBL] [Abstract][Full Text] [Related]
32. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition.
Rodrigues CM; Stieers CL; Keene CD; Ma X; Kren BT; Low WC; Steer CJ
J Neurochem; 2000 Dec; 75(6):2368-79. PubMed ID: 11080188
[TBL] [Abstract][Full Text] [Related]
33. Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells.
Lim SC; Duong HQ; Parajuli KR; Han SI
Oncol Rep; 2012 Oct; 28(4):1429-34. PubMed ID: 22824956
[TBL] [Abstract][Full Text] [Related]
34. Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding.
Kren BT; Rodrigues CM; Setchell KD; Steer CJ
Liver Transpl; 2001 Apr; 7(4):321-34. PubMed ID: 11303292
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
[TBL] [Abstract][Full Text] [Related]
36. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.
Liu H; Qin CY; Han GQ; Xu HW; Meng M; Yang Z
World J Gastroenterol; 2007 Mar; 13(11):1652-8. PubMed ID: 17461466
[TBL] [Abstract][Full Text] [Related]
38. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG
Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896
[TBL] [Abstract][Full Text] [Related]
39. Effect of ursodeoxycholic acid on TGF beta1/Smad signaling pathway in rat hepatic stellate cells.
Liang TJ; Yuan JH; Tan YR; Ren WH; Han GQ; Zhang J; Wang LC; Qin CY
Chin Med J (Engl); 2009 May; 122(10):1209-13. PubMed ID: 19493473
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
